Release date: 31 July 2018
Promoter – Financial Intermediary
JENNEWEIN BIOTECHNOLOGIE GMBHLocation
Description
Jennewein is a highly innovative German biotechnology food company focused on novel production processes for the synthesis of human milk oligosaccharides (functional nutritive sugars) for a wide range of applications, including nutritional, pharmaceutical and cosmetic products.
Objectives
The project will cover research and development (R&D) costs, both operational expenditure (OPEX) and capital expenditure (CAPEX) related to the up-scaling of the production of the human milk oligosaccharides, clinical trials for the new products and related R&D activities.
Sector(s)
- Services - Professional, scientific and technical activities
Proposed EIB finance (Approximate amount)
EUR 15 million
Total cost (Approximate amount)
EUR 40 million
Environmental aspects
The project mainly concerns investments in R&D that are expected to be carried out in existing facilities already authorised for the same purpose and would therefore not require an environmental impact assessment (EIA) under the Directive 2011/92/EU. Full environmental details will be verified during the appraisal.
Procurement
The promoter is a private company, not operating in the utilities sector and does not have the status of a contracting authority; thus the project is not subject to the EU directives on procurement.
Status
Signed - 20/07/2018